Alb-Cre-Tg/H11-CAG-LSL-Myc

Nomenclature

B6.Cg-Tg(Alb-Cre)Igs2em1(CAG-LSL-Myc)Smoc

Cat. NO.

NM-KI-220458

Strain State

Repository Live

Export PDF

Model Description

Alb-Cre-Tg was crossed with H11-CAG-LSL-Myc(NM-KI-00039) to generate Alb-Cre-Tg/H11-CAG-LSL-Myc.

Validation Data

image.png

Fig.1 Survival analysis of H11-CAG-LSL-Myc ; Alb-Cre mice (n>100).

image.png

Fig.2 Gross appearance of the livers in WT and H11-CAG-LSL-Myc ; Alb-Cre mice.

image.png

Fig.3 Detection of mouse AFP expression in WT and H11-CAG-LSL-Myc ; Alb-Cre mice by WB. 

Abbr. M, marker; WT, wild type; L, liver; T, tumor; TA, tumor-adjacent tissues.

image.png

Fig.4 Detection of mouse GPC3 expression in serum in WT and H11-CAG-LSL-Myc ; Alb-Cre mice by ELISA.

Abbr. WT, wild type; N.D. not detected.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more